Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

AMOXAPEN 250 CAPSULE 250 mg - HSA Drug Approval Details

Approvals/HSA/AMOXAPEN 250 CAPSULE 250 mg

Approved

THERAPEUTIC

AMOXAPEN 250 CAPSULE 250 mg

REMEDICA LTD (CYPRUS)🇸🇬 Health Sciences Authority

Approval Date: Jun 1, 1988
Approval ID: 869f4cf8c3335caf
Company: REMEDICA LTD (CYPRUS)
Type: Therapeutic

Approval Details

Approval Id: 869f4cf8c3335caf
Drug Name: AMOXAPEN 250 CAPSULE 250 mg
Product Name: AMOXAPEN 250 CAPSULE 250 mg
Approval Number: SIN01607P
Approval Date: 1988-06-01
Registrant: GOLDPLUS UNIVERSAL PTE LTD
Licence Holder: GOLDPLUS UNIVERSAL PTE LTD
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: CAPSULE
Route Of Administration: ORAL
Atc Code: J01CA04
Atc Item Name: amoxicillin
Pharma Manufacturer Name: GOLDPLUS UNIVERSAL PTE LTD

Active Ingredients

AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN

250 mg

AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN

250 mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jun 1, 1988

Approval ID

869f4cf8c3335caf

Type

Therapeutic

Back to HSA Approvals